Stock VER.H VERISANTE TECHNOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Verisante Technology Inc. Stock Toronto S.E.

Equities

VER.H

CA92346G2036

Advanced Medical Equipment & Technology

Delayed Toronto S.E.
Other stock markets
 09:30:05 2024-04-25 am EDT 		5-day change 1st Jan Change
0.01 CAD 0.00% Intraday chart for Verisante Technology Inc. 0.00% -33.33%
Apr. 20 Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 30 Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Financials

Sales 2022 - Sales 2023 - Capitalization 505.33 690.59
Net income 2022 1M 1.37M Net income 2023 - 0 EV / Sales 2022 -
Net cash position 2022 85.78K 117K Net cash position 2023 30.42K 41.58K EV / Sales 2023 -
P/E ratio 2022
0.2 x
P/E ratio 2023
-
Employees 18
Yield 2022 *
-
Yield 2023
-
Free-Float 24.48%
More Fundamentals * Assessed data

Chart Verisante Technology Inc.

Dynamic Chart

Latest news about Verisante Technology Inc.

Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Verisante Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Verisante Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Verisante Technology Inc. Auditor Raises 'Going Concern' Doubt CI
Verisante Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Verisante Technology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Verisante Technology Inc. announced that it has received CAD 0.09858 million in funding CI
Verisante Technology Inc. announced that it expects to receive CAD 0.09858 million in funding CI
Verisante Technology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Verisante Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Verisante Technology Inc. Auditor Raises 'Going Concern' Doubt CI
Verisante Technology Inc. Auditor Raises 'Going Concern' Doubt CI
More news

Press releases Verisante Technology Inc.

Verisante: Q4 Earnings Snapshot AQ
Verisante: Q2 Earnings Snapshot AQ
Verisante: Q3 Earnings Snapshot AQ
VERISANTE ANNOUNCES SHARE CONSOLIDATION AQ
VERISANTE TECHNOLOGY INC. ANNOUNCES SHARE ISSUANCE AQ
More press releases

Quotes and Performance

3 months-33.33%
6 months-33.33%
Current year-33.33%
More quotes

Highs and lows

1 week
0.01
Extreme 0.01
0.01
1 month
0.01
Extreme 0.01
0.02
Current year
0.01
Extreme 0.01
0.02
1 year
0.01
Extreme 0.01
0.03
3 years
0.01
Extreme 0.01
0.20
5 years
0.01
Extreme 0.01
0.20
10 years
0.01
Extreme 0.01
2.00
More quotes

Managers and Directors - Verisante Technology Inc.

Managers TitleAgeSince
Thomas Braun FOU
 Founder 56 06-03-06
Emmeline Braun DFI
 Director of Finance/CFO - -
Members of the board TitleAgeSince
Thomas Braun FOU
 Founder 56 06-03-06
Jake J. Thiessen BRD
 Director/Board Member - 09-08-06
Emmeline Braun DFI
 Director of Finance/CFO - -
More insiders

Quotes

Date Price Change Volume
24-04-25 0.01 0.00% 1,100

Delayed Quote Toronto S.E., April 25, 2024 at 09:30 am EDT

More quotes

Company Profile

Verisante Technology, Inc. is a Canada-based company. The Company is engaged in seeking out opportunities to acquire a business, such as a provider of technologies and services, offering scalable solutions. It intends to focus its search on companies that meet its acquisition target characteristics within the life sciences sectors, specifically medical devices; pharmaceuticals; health data information technology infrastructure; and health data analytics and big data.
Sector
Advanced Medical Equipment & Technology
Calendar
2024-07-28 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.08% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.83% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.42% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.24% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.48% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+12.36% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.24% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+13.05% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. VRSEF Stock
  4. VER.H Stock